Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
8.94
+0.14 (1.59%)
At close: Dec 5, 2025, 4:00 PM EST
8.99
+0.05 (0.55%)
After-hours: Dec 5, 2025, 7:37 PM EST
Greenwich LifeSciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -19.48 | -15.79 | -8.89 | -7.83 | -4.57 | -1.86 | |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | |
| Stock-Based Compensation | 10.1 | 7.25 | 2.38 | 1.74 | 0.66 | 0.68 | |
| Change in Accounts Payable | 0.33 | 0.92 | 0.04 | - | -0.53 | -0.09 | |
| Change in Other Net Operating Assets | 0.45 | 0.34 | -0 | -0.12 | 0.14 | 0.12 | |
| Operating Cash Flow | -8.59 | -7.27 | -6.48 | -6.2 | -4.29 | -1.15 | |
| Short-Term Debt Repaid | - | - | - | - | -0.28 | -0.36 | |
| Total Debt Repaid | - | - | - | - | -0.28 | -0.36 | |
| Net Debt Issued (Repaid) | - | - | - | - | -0.28 | -0.36 | |
| Issuance of Common Stock | 6.58 | 4.37 | - | - | 3.36 | 33.65 | |
| Repurchase of Common Stock | - | - | - | -7.54 | - | - | |
| Other Financing Activities | - | - | - | - | -0.25 | -3.48 | |
| Financing Cash Flow | 6.58 | 4.37 | - | -7.54 | 2.84 | 29.81 | |
| Net Cash Flow | -2.02 | -2.9 | -6.48 | -13.74 | -1.46 | 28.65 | |
| Levered Free Cash Flow | -1.36 | -1.49 | -3.42 | -3.4 | -2.59 | -0.45 | |
| Unlevered Free Cash Flow | -1.36 | -1.49 | -3.42 | -3.4 | -2.59 | -0.45 | |
| Change in Working Capital | 0.78 | 1.27 | 0.03 | -0.12 | -0.39 | 0.03 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.